High-dose influenza vaccine shows no additional benefit for heart disease patients

News Release

Friday, December four, 2020

NIH-funded study finds bigger dose is not more successful at lowering critical flu complications in this higher-danger group.

Superior-dose influenza (commonly acknowledged as flu) vaccines are no improved than common-dose influenza vaccines in lowering fatalities and hospitalizations amid people with fundamental coronary heart illness, according to a huge study publishing in JAMA. The results do not change very well-recognized conclusions about the price of an once-a-year influenza vaccine for individuals with coronary heart illness and other chronic sicknesses, and do not change the advice for an once-a-year influenza vaccine for most persons. 

The study was funded by the National Heart, Lung, and Blood Institute (NHLBI), element of the National Institutes of Well being, and seems on the internet on December four.

“Getting a vaccine is even more essential than normal this yr, as persons with COVID-19 who get the flu are at bigger danger for more critical complications,” explained Lawton S. Cooper, M.D., M.P.H., 1 of the study’s co-authors and a researcher with the Medical Purposes and Avoidance Branch, Division of Cardiovascular Sciences, NHLBI. “People need to observe the steering of their health care supplier as to which flu vaccine, higher or reduced dose, is improved for them, but acquiring the flu shot is more vital than which dose.”

Researchers have acknowledged for some time that persons with cardiovascular illness are at bigger danger for creating critical complications from influenza, which include coronary heart assaults, hospitalizations for coronary heart failure, and demise. As a end result, specialists have strongly advisable that this group get an influenza vaccine, and at minimum 1 study has advised that a higher-dose model could assistance reduce these complications more than the common-dose vaccine.

To establish if there is reward in the bigger dose, the NHLBI funded the Influenza Vaccine to Successfully Stop Cardio Thoracic Functions and Decompensated coronary heart failure (INVESTED) demo, a randomized, double-blind demo carried out at 157 medical centers in the United States and Canada about a few influenza seasons. The demo, which was introduced in September 2016, integrated a full of five,260 people who experienced been lately hospitalized for a cardiovascular party, which include coronary heart attack within the preceding yr or coronary heart failure within the preceding two years.

Every participant also experienced 1 or more more danger factors for cardiovascular disease—for case in point, they were being age sixty five or more mature, smoked, or experienced variety two diabetes, obesity, kidney illness, peripheral artery illness, or a heritage of stroke.

At the end of the study, the composite full of hospitalizations and fatalities was around equal for the two flu vaccine groups. The scientists observed 883 hospitalizations because of to cardiovascular or pulmonary results in and 92 fatalities from any result in in the higher-dose vaccine group, whilst they saw 846 hospitalizations for these situations and seventy eight fatalities from any result in in the common-dose vaccine group. The big difference was not statistically sizeable.

Orly Vardeny, Pharm.D., M.S., direct researcher of the study and associate professor of medicine at the University of Minnesota’s Clinical School and University of Pharmacy, Minneapolis, explained there are a few of probable explanations for the conclusions. “First, we enrolled persons at higher danger for coronary heart and lung-related hospitalizations,” she explained, “so it is probable that the incremental reward of 1 vaccine about the other would not have overcome the higher fundamental danger in this population.” Whilst there were being many hospitalizations through the demo, only a tiny number were being recognized as triggered by influenza, therefore a different probability is that since all contributors received the influenza vaccine, the two the higher- and reduced-dose formulation equally lowered their danger for coronary heart and lung hospitalizations, Vardeny explained.

Whilst there were being couple of vaccine-related side outcomes in either group, people who received higher-dose vaccines tended to have more usual injection-related side outcomes, these as soreness, swelling, and muscle mass aches.

“It’s vital to bear in mind that all contributors in INVESTED received a vaccination, and that the two vaccine formulations were being frequently very well tolerated with extremely couple of people experiencing severe adverse reactions, with no big difference involving groups,” explained Scott Solomon, M.D., study co-leader and professor of medicine at Harvard Clinical School. “Unfortunately, many higher-danger cardiovascular people do not get vaccinated at all. For lowering hospitalizations because of to coronary heart and lung complications, just acquiring vaccinated with any influenza vaccine may perhaps considerably lessen danger in our higher-danger people.”

The scientists pointed out caveats in the study, which include its concentration on people with a higher danger for cardiovascular illness, use of vaccine formulations out there through the 2016-17, 2017-18, and 2018-19 influenza seasons, and use of vaccines that were being organized in hen eggs. The scientists explained upcoming studies need to analyze irrespective of whether other forms of flu vaccine may perhaps be more protective for people with higher-danger conditions or irrespective of whether a higher-dose vaccine rewards reduced-danger cardiac people more.

This study is supported by grants from the NHLBI (U01HL130163 and U01HL130204).

EDITOR’S Note: The National Influenza Vaccination 7 days, observed from December six-twelve, highlights the importance of influenza vaccination.

About the National Heart, Lung, and Blood Institute (NHLBI): NHLBI is the global leader in conducting and supporting investigation in coronary heart, lung, and blood disorders and sleep problems that advancements scientific expertise, improves general public wellbeing, and will save lives. For more information and facts, visit 

About the National Institutes of Well being (NIH):
NIH, the nation’s medical investigation company, features 27 Institutes and Centers and is a component of the U.S. Division of Well being and Human Expert services. NIH is the main federal company conducting and supporting essential, medical, and translational medical investigation, and is investigating the results in, treatment plans, and cures for the two widespread and rare disorders. For more information and facts about NIH and its packages, go to www.nih.gov.

NIH…Turning Discovery Into Well being^®

###